Recombinant multi-species CACNA2D3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CACNA2D3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CACNA2D3,Cacna2d3,Cacnad3,HSA272268,Voltage-dependent calcium channel subunit alpha-2/delta-3,Voltage-gated calcium channel subunit alpha-2/delta-3,alapha2delta3

Target products collectionGo to CACNA2D3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0129-Ag-1/ GM-Tg-hg-IP0129-Ag-2 Human CACNA2D3 protein Human
GM-Tg-rg-IP0129-Ag-1/ GM-Tg-rg-IP0129-Ag-2 Rat CACNA2D3 protein Rat
GM-Tg-mg-IP0129-Ag-1/ GM-Tg-mg-IP0129-Ag-2 Mouse CACNA2D3 protein Mouse
GM-Tg-cynog-IP0129-Ag-1/ GM-Tg-cynog-IP0129-Ag-2 Cynomolgus/Rhesus macaque CACNA2D3 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0129-Ag-1/ GM-Tg-felg-IP0129-Ag-2 Feline CACNA2D3 protein Feline
GM-Tg-cang-IP0129-Ag-1/ GM-Tg-cang-IP0129-Ag-2 Canine CACNA2D3 protein Canine
GM-Tg-bovg-IP0129-Ag-1/ GM-Tg-bovg-IP0129-Ag-2 Bovine CACNA2D3 protein Bovine
GM-Tg-equg-IP0129-Ag-1/ GM-Tg-equg-IP0129-Ag-2 Equine CACNA2D3 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0129-Ag-1/ GM-Tg-hg-IP0129-Ag-2; GM-Tg-rg-IP0129-Ag-1/ GM-Tg-rg-IP0129-Ag-2;
GM-Tg-mg-IP0129-Ag-1/ GM-Tg-mg-IP0129-Ag-2; GM-Tg-cynog-IP0129-Ag-1/ GM-Tg-cynog-IP0129-Ag-2;
GM-Tg-felg-IP0129-Ag-1/ GM-Tg-felg-IP0129-Ag-2; GM-Tg-cang-IP0129-Ag-1/ GM-Tg-cang-IP0129-Ag-2;
GM-Tg-bovg-IP0129-Ag-1/ GM-Tg-bovg-IP0129-Ag-2; GM-Tg-equg-IP0129-Ag-1/ GM-Tg-equg-IP0129-Ag-2
Products Name CACNA2D3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CACNA2D3
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CACNA2D3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.